DE FRANCESCO, ERNESTINA MARIANNA
 Distribuzione geografica
Continente #
EU - Europa 630
NA - Nord America 487
AF - Africa 79
AS - Asia 24
OC - Oceania 5
SA - Sud America 2
Totale 1.227
Nazione #
US - Stati Uniti d'America 482
IT - Italia 297
IE - Irlanda 197
NG - Nigeria 50
BE - Belgio 42
RU - Federazione Russa 30
CI - Costa d'Avorio 20
GB - Regno Unito 16
CN - Cina 11
NL - Olanda 10
DE - Germania 9
SN - Senegal 9
UA - Ucraina 9
SE - Svezia 7
IN - India 6
AU - Australia 5
CA - Canada 5
GR - Grecia 3
RO - Romania 3
SG - Singapore 3
CH - Svizzera 2
FI - Finlandia 2
UZ - Uzbekistan 2
CL - Cile 1
ES - Italia 1
FR - Francia 1
JP - Giappone 1
LB - Libano 1
PE - Perù 1
PL - Polonia 1
Totale 1.227
Città #
Dublin 197
Chandler 136
Catania 100
Abuja 50
Cambridge 48
Lawrence 48
Andover 47
Agrigento 30
Des Moines 29
Brussels 26
Abidjan 20
Paternò 20
Wilmington 16
Ashburn 11
Dakar 9
Izegem 9
Rotterdam 9
Redmond 7
Aci Castello 6
Bari 6
Boardman 6
Cosenza 6
Gravina di Catania 5
Antea 4
Bronte 4
Grafing 4
Hobart 4
Padova 4
Palermo 4
Plymouth 4
Temse 4
Toronto 4
Casarsa della Delizia 3
Jacksonville 3
Lentini 3
London 3
Maletto 3
Manchester 3
Nanjing 3
New Delhi 3
Norwalk 3
Pune 3
Redwood City 3
Saint Petersburg 3
Seattle 3
Ternat 3
Aci Catena 2
Adrano 2
Boca 2
Borås 2
Chiaramonte Gulfi 2
Hebei 2
Los Angeles 2
Messina 2
Piemonte 2
Randazzo 2
Salerno 2
Scicli 2
Amsterdam 1
Bremen 1
Bukhara 1
Changsha 1
Florence 1
Guangzhou 1
Helsinki 1
Islington 1
Jiaxing 1
Lanzhou 1
Lappeenranta 1
Lima 1
Ludwigshafen 1
Markham 1
Melbourne 1
Milan 1
Modica 1
Moscow 1
Nishinotoindori 1
Phoenix 1
Radeberg 1
Ramacca 1
Rockville 1
Saint Paul 1
San Francisco 1
Singapore 1
Velletri 1
Totale 970
Nome #
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 81
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets 51
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 50
Novel mechanisms of tumor promotion by the insulin receptor isoform a in triple-negative breast cancer cells 46
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 46
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis 41
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells 38
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 36
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling 36
Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells 35
GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts 34
The G protein estrogen receptor (GPER) is regulated by endothelin-1 mediated signaling in cancer cells 33
Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling 30
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 27
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts 26
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis 24
Crosstalk between notch, HIF-1α and GPER in breast cancer EMT 24
G protein-coupled receptors at the crossroad between physiologic and pathologic angiogenesis: Old paradigms and emerging concepts 24
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 23
COVID-19 and Diabetes: The Importance of Controlling RAGE 23
Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells 23
A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: Mechanisms and models 23
The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1α (HIF-1α) in breast cancer cells and cardiomyocytes 23
Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine) 23
Cancer stem cells (CSCs): Metabolic strategies for their identification and eradication 22
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy 21
A Bodipy as a luminescent probe for detection of the G protein estrogen receptor (GPER) 21
Crucial role of phospholamban phosphorylation and s-nitrosylation in the negative lusitropism induced by 17β-estradiol in the male rat heart 21
Cross-talk between GPER and growth factor signaling 21
Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts 21
Editorial: Early diagnoses and treatments of uncommon breast cancers 20
Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC) 20
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs) 20
Estrogen Receptors and Chronic Venous Disease 20
The cholesterol metabolite 25-Hydroxycholesterol activates estrogen receptor α-Mediated signaling in cancer cells and in cardiomyocytes 19
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX 18
The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells 17
Multifactorial regulation of GPER expression in cancer cells and cardiomyocytes 15
GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells 15
Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs) 15
NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness" 15
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress 14
Two novel GPER agonists induce gene expression changes and growth effects in cancer cells 14
GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment 14
Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) Activity 13
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer 13
GPER mediates activation of HIF1α/VEGF signaling by estrogens 13
Pregnancy augments G protein estrogen receptor (GPER) induced vasodilation in rat uterine arteries via the nitric oxide - cGMP signaling pathway 13
SLC37A1 Gene expression is up-regulated by epidermal growth factor in breast cancer cells 13
GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells 13
Notch1 mediates preconditioning protection induced by GPER in normotensive and hypertensive female rat hearts 13
GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response 13
Protective Role of GPER Agonist G-1 on Cardiotoxicity Induced by Doxorubicin 13
GPER Mediates Cardiotropic Effects in Spontaneously Hypertensive Rat Hearts 12
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) 12
Niacin activates the G protein estrogen receptor (GPER)-mediated signalling 12
Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy 11
Editorial: A year in review: discussions in molecular and structural endocrinology 9
Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic State 8
Totale 1.364
Categoria #
all - tutte 6.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 6 3 7 0 0 0 0 0 0 0 0 0
2020/2021114 0 0 0 0 3 0 17 12 22 50 8 2
2021/2022341 8 46 37 1 56 0 65 17 8 0 13 90
2022/2023644 57 43 22 37 20 81 29 88 122 15 38 92
2023/2024237 7 69 10 49 11 37 5 14 12 23 0 0
Totale 1.364